* PainReform Ltd PRFX.OQ reported a quarterly adjusted loss
of 23 cents per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 56 cents per
share.
* Reported revenue was zero; analysts expected zero.
* PainReform Ltd's reported EPS for the quarter was a loss of 23
cents.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* PainReform Ltd shares had fallen by 47.3% this quarter and
lost 47.9% so far this year.
* The company reported a quarterly loss of $2.04 million.
* Wall Street's median 12-month price target for PainReform Ltd
is $10.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated May 13 at 06:06 p.m. GMT.
All figures in US dollars